← Back to headlines
Cellares' Cell Shuttle Used in First Cabaletta Bio CAR T Therapy Infusions
Cellares' Cell Shuttle platform has been utilized for the first patient infusions of Cabaletta Bio's CAR T cell therapy, marking a significant step in the development of advanced cell therapies.
15 Apr, 06:14 — 15 Apr, 06:14
Sources
Showing 1 of 1 sources



